Chromium picolinate monohydrate (CPM) is a synthetic compound heavily marketed to consumers in the United States for use as a dietary supplement for muscle building and weight loss. The National Toxicology Program (NTP) tested the toxicity of this compound based on the potential for widespread consumer exposure and lack of information about its toxicity. Groups of 10 male and 10 female F344/N rats and B6C3F(1) mice were exposed to 0, 80, 240, 2000, 10,000, or 50,000 ppm CPM in feed for 13 weeks. CPM administration produced no effect on body weight gain or survival of rats or mice. Organ weights and organ/body weight ratios in exposed animals were generally unaffected by CPM. No compound-related changes in hematology and clinical chemistry parameters were observed. There were no histopathological lesions attributed to CPM in rats or mice.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.fct.2004.08.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Report on the mutagenicity of flavone derivatives and their contribution to advancing scientific knowledge.
Proc Jpn Acad Ser B Phys Biol Sci
December 2024
Graduate Division of Nutritional and Environmental Sciences, University of Shizuoka, Shizuoka, Japan.
Flavonoids, such as quercetin and kaempferol, and their glycosides, are widely distributed in vegetables and fruits. Sugimura, T. et al.
View Article and Find Full Text PDFAdolescent oral oxycodone self-administration disrupts neurobehavioral and neurocognitive development.
Neuropharmacology
November 2024
Cognitive and Neural Science Program, Department of Psychology, Barnwell College, University of South Carolina, 1512 Pendleton Street, Columbia, SC, 29208, USA.
Nonmedical use of prescription opioids peaks during late adolescence, a developmental period associated with the maturation of higher-order cognitive processes. To date, however, how chronic adolescent oxycodone (OXY) self-administration alters neurobehavioral (i.e.
View Article and Find Full Text PDFStrain and sex-related behavioral variability of oxycodone dependence in rats.
Neuropharmacology
October 2023
Department of Psychiatry, University of California San Diego, School of Medicine, La Jolla, CA, USA. Electronic address:
Over the past two decades, the escalating prescription of opioid medications for pain management has culminated in a widespread opioid epidemic, significantly impacting public health, social dynamics, and economic stability. The urgent need for improved treatments for opioid addiction necessitates a deeper understanding of its biological underpinnings, with genetic variations playing a crucial role in individual susceptibility to opioid use disorder (OUD) and influencing clinical practices. In this study, we leverage the genetic diversity of four rat strains (ACI/N, BN/NHsd, WKY/N, and F344/N) to examine the contribution of genetic factors to oxycodone metabolism and addiction-like behaviors.
View Article and Find Full Text PDFWhole exome and transcript profiling of liver following aflatoxin B1 exposure in rats.
J Appl Toxicol
September 2023
Division, National Toxicology Program, NIEHS, Durham, North Carolina, USA.
We recently developed a rat whole exome sequencing (WES) panel and used it to evaluate early somatic mutations in archival liver tissues from F344/N rats exposed to the hepatocarcinogen, Aflatoxin B1 (AFB1), a widely studied, potent mutagen and hepatocarcinogen associated with hepatocellular carcinoma (HCC). Rats were exposed to 1-ppm AFB1 in feed for 14, 90, and 90 days plus a recovery 60-day, non-exposure period (150-day) timepoint. Isolated liver DNA was exome sequenced.
View Article and Find Full Text PDFCyba and Nox2 mutant rats show different incidences of eosinophilia in the genetic background- and sex-dependent manner.
Exp Anim
May 2023
Division of Animal Research, Research Center for Supports to Advanced Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan.
Article Synopsis
- The Matsumoto Eosinophilia Shinshu (MES) is a rat model exhibiting 100% eosinophilia in both genders due to a loss-of-function mutation in the Cyba gene, which affects the superoxide-generating NADPH oxidase complex.
- Recent studies revealed that loss of the NOX2 enzyme is specifically responsible for causing blood eosinophilia in these rats, while the influence of genetic background and gender also play roles in the disorder's development.
- The findings from this research involving various rat strains aim to help understand the molecular mechanisms leading to eosinophilia and could inform future studies on the disease.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!